Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6211257 | 1.00 | TSHR (0.48) | TSHRALDH1A1NAAAHTTSMN1; SMN2 | |
| SCHEMBL6210209 | 1.00 | TSHR (0.48) | TSHRALDH1A1NAAAHTTSMN1; SMN2 | |
| SCHEMBL28759574 | 0.80 | TSHR (0.56) | TSHRALDH1A1NAAASMN1; SMN2NPC1 | |
| SCHEMBL28106389 | 0.79 | TSHR (0.65) | TSHRALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL8178555 | 0.79 | TSHR (0.48) | TSHRNAAAHTTSMN1; SMN2CA1 | |
| SCHEMBL19600798 | 0.79 | TSHR (0.48) | TSHRALDH1A1NAAAHTTSMN1; SMN2 | |
| SCHEMBL24488934 | 0.78 | TSHR (0.52) | TSHRALDH1A1NAAAHTTSMN1; SMN2 | |
| SCHEMBL711863 | 0.78 | ALDH1A1 (0.57) | TSHRALDH1A1HTTSMN1; SMN2TDP1 | |
| SCHEMBL1109806 | 0.78 | TSHR (0.52) | TSHRALDH1A1NAAAHTTSMN1; SMN2 | |
| SCHEMBL14253597 | 0.76 | TSHR (0.50) | TSHRALDH1A1NAAAHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7358396-B2 | Preparation of optically active amines | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-15 | — | — | US | disclosed |
| US-7078226-B1 | Method for producing optically active amines | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-18 | — | — | US | disclosed |
| US-20060122429-A1 | Preparation of optically active amines | DITRICH KLAUS | 2006-06-08 | — | — | US | disclosed |
| EP-0194554-B1 | PROCESS FOR PRODUCTION OF OXIME DERIVATIVES | NIPPON ZEON CO., LTD. (JP) | 1993-09-01 | — | — | EP | disclosed |
| US-4906768-A | Process for production of oxime derivatives | NIPPON ZEON CO., LTD. (JP) | 1990-03-06 | — | — | US | disclosed |
| EP-0194554-A2 | Process for production of oxime derivatives | NIPPON ZEON CO., LTD. (JP) | 1986-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122429-A1 | Preparation of optically active amines | MAOA, MAOB, NAAA | TSHR 2708/4885ALDH1A1 283/4885NAAA 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.